U.S. researchers say an implantable device may be a cost-effective way to treat high blood pressure and its effects.
The device, called Rheos, is being tested at the University of Rochester Medical Center in New York on drug-resistant hypertension patients.
The findings, published in the Journal of Clinical Hypertension, are based on data from two large population-based studies that compare the incidence of adverse health events -- such as stroke and heart attack -- for groups of individuals with and without the device.
The researchers also projected the healthcare costs associated with those events over a patient's lifetime and concluded if Rheos continues to perform as it has in ongoing clinical trials, the device is a cost-effective way to control hypertension.
Rheos, being developed by CVRx Inc. of Minneapolis consists of a battery-powered implantable generator, inserted under the skin near the collarbone, and two carotid sinus leads, which run from the generator to the left and right carotid sinus in the neck.
No comments:
Post a Comment